Ribosomal protein S19 pseudogene 7 (RPS19P7)

Ribosomal protein S19 pseudogene 7 (RPS19P7) is a non-functional pseudogene belonging to the ribosomal protein S19 gene family. Unlike the functional ribosomal protein S19 (RPS19), which is essential for ribosome biogenesis and is implicated in diseases such as Diamond-Blackfan anemia[3][5][7][9], RPS19P7 does not encode an active protein and is not involved in molecular mechanisms, disease biology, or therapeutic modulation[1][8]. As a pseudogene, RPS19P7 does not serve as a therapeutic target, biomarker, or regulator of biological functions. There is no evidence supporting its role in drug interaction or safety concerns, nor is it related to any molecular family like receptors, enzymes, or channels[1][8]. The structure and disease relevance discussed in the literature refer to the functional gene RPS19, not this pseudogene[3][5][7]. RPS19P7 is sometimes listed in databases for reference or genomic studies, but it is not considered a genuine target for therapeutic development and does not have described biological or pathological functions[1][8]. Entry is considered "incorrect" in the context of therapeutic targets as it refers to a pseudogene. RPS19P7 is a pseudogene (non-coding, non-functional) of ribosomal protein S19. Not a target: Does not encode a protein or serve as a receptor, enzyme, transporter, or transcription factor[1][8]. No biological or disease functions, drug interactions, or safety concerns are described for this entity. Aliases and database references: RPS19_3_1038, RPS19P7[1][8]. If seeking a therapeutic target relevant for ribosome-related diseases or drug discovery, consider the functional ribosomal protein S19 (RPS19), not RPS19P7[3][5][7][9].

Other names

RPS19_3_1038RPS19P7